Facebook
Twitter
LinkedIn
Forward
2022 Multidisciplinary Head and Neck Cancers Symposium - Live Stream
This meeting provides the most up-to-date information on multidisciplinary therapies, the latest clinical research, new treatment strategies, supportive care, scientific breakthroughs and toxicity mitigation.
Target Audience
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.
Learning Objectives
Upon completion of this live activity, attendees should be able to do the following:
- Explain the importance of multidisciplinary care in head and neck cancer (HNC) and how to best apply it for optimal outcomes.
- Describe key advances in systemic therapy, including targeted therapy and immunotherapy in HNC.
- Discuss recent advances in minimally invasive surgery in HNC and when to apply it in treating early and locally advanced disease.
- Illustrate how we can improve disparities in head and neck cancer care.
- Determine the importance of interventions in survivorship clinics for long term side effects.
- Describe key advances in radiation therapy delivery, targeting and differences between various modalities, including novel treatment approaches such as proton and FLASH radiotherapy.
- Discuss complex cases in HNC and how to best utilize current knowledge for decision-making.
- Manage toxicities related to the management of head and neck cancer.
- Summarize key recent advances in HNC biology.
- Summarize key recent advances in HNC imaging.
- Discuss and implement standard treatment guidelines for various subtypes of HNCs.
Physicians
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME certificates of credit are only available to participants who have completed the online evaluation tool.
Physicists
This activity has been approved for a maximum of 18.24 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Program (CAMPEP).
Physicist attendees will receive a confirmation certificate of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting. Your official certificate will be available from CAMPEP.
Available Credit
- 17.75 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 17.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 17.75 Certificate of AttendanceThis activity was designated for 17.75 AMA PRA Category 1 Credit™.
- 18.24 CAMPEPThis activity has been approved for 18.24 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
Price
Please only evaluate the sessions you attended.
CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants will have online access to their certificate upon completion of the evaluation. Participants can access, print and save their certificate from ASTRO Academy.
Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.